Clinical Trials in Phoenix

Showing 1381-1400 of 14,291 trials

COMPLETEDPhase 3< 1 mile

Phase 3 Evaluation of the Safety and Efficacy of LNZ100 & LNZ101 for the Treatment of Presbyopia

NCT05656027

Phase 3 study to evaluate the safety and effectiveness of LNZ100 \& LNZ101 for the treatment of Presbyopia.

PresbyopiaRefractive ErrorEye Diseases+1 more

LENZ Therapeutics, Inc469 participantsStarted Dec 2022

Chandler, Arizona, United States • Mesa, Arizona, United States • Phoenix, Arizona, United States +22 more locations

RECRUITINGNA< 1 mile

Prophylactic Reinforcement of Ventral Abdominal Incisions Trial

NCT03911700

This trial is being conducted to evaluate the efficacy of Phasix™ Mesh implantation at the time of midline fascial closure compared to primary suture closure in preventing a subsequent incisional hernia in subjects at risk for incisional hernia after open midline laparotomy surgery.

Open Midline Laparotomy

C. R. Bard477 participantsStarted Dec 2019

Phoenix, Arizona, United States • Los Angeles, California, United States • San Francisco, California, United States +41 more locations

Phase 3 Evaluation of the Safety and Efficacy of LNZ100 & LNZ101 for the Treatment of Presbyopia

Prophylactic Reinforcement of Ventral Abdominal Incisions Trial

Find Trials by Condition in Phoenix

The ENCIRCLE Trial

A Multicenter, Randomized Study in Participants With Diabetic Retinopathy Without Center-involved Diabetic Macular Edema To Evaluate the Efficacy, Safety, and Pharmacokinetics of Ranibizumab Delivered Via the Port Delivery System Relative to the Comparator Arm

WatchWell: Simple and Practical Strategies to Reduce the Negative Health Impact of Sedentary Screen Time

ADP-A2M4CD8 Monotherapy and in Combination With Nivolumab in HLA-A2+ Subjects With MAGE-A4 Positive Ovarian Cancer (SURPASS-3)

A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)

Clinical Validation of the RENISCHEM L-FABP POC Assay

A Study of TAK-788 in Adults With Non-Small Cell Lung Cancer

A Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Solid Tumors

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in People Who Have a Body Weight Above the Healthy Range

Study of Efficacy and Safety of Pembrolizumab Plus Platinum-based Doublet Chemotherapy With or Without Canakinumab in Previously Untreated Locally Advanced or Metastatic Non-squamous and Squamous NSCLC Subjects

Primary Tumor Research and Outcomes Network

Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy

Reducing Potentially Inappropriate Medication Prescribing for Older Patients in the ED

Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms

The RESET Clinical Trial: SPRINT® Peripheral Nerve Stimulation for the Treatment of Back Pain

A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer

Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer